Zhaoyang Q. Tang

Shantou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

BIPE: Artificial Intelligence-Driven Peptide Bitterness Intensity Prediction Engine.

BIPE: Artificial Intelligence-Driven Peptide Bitterness Intensity Prediction Engine.

Journal: Journal of chemical information and modeling
Published: January 20, 2026

T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity.

T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity.

Journal: Cell reports
Published: May 07, 2025

Establishment of reference intervals for serum immunoglobulin G N-glycosylation features in healthy Chinese adults: a nationwide survey in the framework of predictive, preventive, and personalized medicine.

Establishment of reference intervals for serum immunoglobulin G N-glycosylation features in healthy Chinese adults: a nationwide survey in the framework of predictive, preventive, and personalized medicine.

Journal: The EPMA journal
Published: April 01, 2025

Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial.

Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial.

Journal: Journal of translational medicine
Published: March 09, 2025

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma.

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma.

Journal: Frontiers in immunology
Published: September 17, 2024

Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma

Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma

Journal: Zhonghua fu chan ke za zhi
Published: May 26, 2024

Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma.

Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma.

Journal: Molecular therapy. Oncology
Published: September 15, 2023

CD4+ anti-TGF-β CAR T cells and CD8+ conventional CAR T cells exhibit synergistic antitumor effects.

CD4+ anti-TGF-β CAR T cells and CD8+ conventional CAR T cells exhibit synergistic antitumor effects.

Journal: Cell reports. Medicine
Published: July 12, 2023

The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer.

The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer.

Journal: International immunopharmacology
Published: March 07, 2023

T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity.

T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity.

Journal: Cell reports
Published: October 03, 2022

CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer.

CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer.

Journal: Clinical and experimental medicine
Published: September 05, 2022

Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels.

Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels.

Journal: Molecular therapy oncolytics
Published: September 04, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026